Medical Science Liaisons (MSLs)

Previous Page 1 of 4 Next >

Search returned 33 items.

sort by: Title | Author | Publication | Date

Trig's Promise

Advocates for the disabled receive Sarah Palin's pledge of support with the wary optimism of a group accustomed to unfulfilled promises.

Date: 09/07/2008 , Publication: MSNBC , Author: By Samantha Henig, Newsweek Web Exclusive

http://www.newsweek.com/id/157341

FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees

The improvements include stricter limits on financial conflicts of interest for committee members, ...

Date: 08/05/2008 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01871.html

Safety-The new Culture of Drug Safety

The new Culture of Drug Safety means embracing the benefit of no doubt about a product's pluses and its minuses. Pharma must learn how patients and prescribers weigh risks and how to spread the word about the advantages.

Date: 07/30/2007 , Publication: Pharmaceutical Executive , Author:

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=446939

Pipeline-Rays of Light

This year's Pipeline Report profiles 32 compounds that are the early fruit of pharma's investment in targeted drug design.

Date: 12/01/2006 , Publication: Pharmaceutical Executive , Author: Staff at Pharmaceutical Executive

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=389274

PPSI to FDA: Regulate acetaminophen labeling

There are data showing that acetaminophen is the No. 1 cause of liver failure...

Date: 11/20/2006 , Publication: Drug Topics , Author: Sandra Levy

http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=385554

Marketing to Professionals: Deep Impact

New research suggests a paradigm shift is needed to gauge MSLs' (medical science liaisons ) true value

Date: 07/01/2006 , Publication: Pharmaceutical Executive , Author: Robin L. Winter-Sperry, MD, Andre Mann, MD

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=352795

FDA Announces New Initiative to Modernize the Regulation of Clinical Trials and Bioresearch Monitoring

The new effort is part of an HHS-wide initiative to employ recent advances in basic science, including genomic...

Date: 06/26/2006 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/NEWS/2006/NEW01396.html

FDA and the Critical Path Institute Announce Predictive Safety Testing Consortium

Consortium Will Share Tests to Understand Safety of Potential New Drugs Earlier

Date: 03/16/2006 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/news/2006/NEW01337.html

FDA Unveils Critical Path Opportunities List Outlining Blueprint To Modernizing Medical Product Development by 2010

Biomarker Development and Clinical Trial Design Greatest Areas for Impact

Date: 03/16/2006 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/news/2006/NEW01336.html

FDA Initiative Helps Expedite Development of Seasonal and Pandemic Flu Vaccines

In two guidance documents released today, one for seasonal, and the other for pandemic influenza vaccines, the FDA provides manufacturers...

Date: 03/02/2006 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/NEWS/2006/NEW01330.html

Previous Page 1 of 4 Next >

Search returned 33 items.